| |
|
|
|
Xtalks, online
2023 -6-23
Getting a drug to market used to be relatively simple and straightforward. That is not the case anymore. Clinical trials, from first-in-human to post-submission, face new challenges every day, including those related to clinical sample collection. Whether it is the treatment for a chronic ambulatory condition, precision medicine or cell and gene therapy, there seems to be a massive rise in complexity.
Most Phase II and Phase III studies have multiple endpoints and procedures per patient generating millions of data points from a single study, and with the exponential rise in technology and capability, these numbers are only going to go up. Not only is this more burdensome for patients and sites to recruit patients, but it also increases the complexity of the logistics and sample handling for trials since data associated with sample collection comprises the majority of data for any submission.
Investigator sites are collecting and handling more laboratory specimens than ever before in support of clinical trials. Laboratory procedures continue to increase in complexity because personalized medicine and customized drug development rely on robust biomarker and genetic data. Highly specialized assays require more customized specimens which often require added processing and more critical procedures for controlled handling. A greater number of biomarkers included in today’s protocols also require more sample aliquots to be created and managed. Taken together, this higher complexity translates to more work for the sites and more opportunities for errors in sample collection, processing, packaging and shipping. One lost or non-viable sample can hamper the ability to enroll a subject in a clinical trial or include data from an enrolled subject in the regulatory submission.
In this 4-part series, attendees will gain new insights and learn best practices from technical and scientific experts on ways to accelerate clinical trials to meet objectives faster. This webinar will address concerns regarding the speed and efficiency of labs involved in complex studies and provide solutions to ensure that they are not getting bogged down. The experts will discuss methods for ensuring that labs are moving fast enough to meet the needs of the patients whose lives depend on them.
Register now to learn more about how to accelerate clinical trials by addressing the challenges of sample collection and sample accuracy.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Kristine Kuryla, Vice President, Project Management, LabConnect April Peltier, Director, Clinical Trial Materials, LabConnect Neha Mohun, Project Manager, Project Management (PRM), LabConnect Taylor Byram, Biology, Project Manager, LabConnect
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -6-23
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|